Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound and Microbubbles for Periprosthetic Joint Infections
NCT07599865Phase 2Recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Aug 2026
- Primary completion
- Jun 2029
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of perflutren in periprosthetic joint infection (PJI) (4 cohorts), sponsored by Thomas Jefferson University. Primary endpoint: Re-Infection Rate at 2 years. Started Aug 2026; status: recruiting.
02
Drugs
perflutren
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT07599865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07599865.